REGORAFENIB IN RECURRENT GLIOBLASTOMA PATIENTS: A MULTICENTRIC REAL-LIFE STUDY

被引：0

作者：

Bruno, Francesco ^{[1
]}

Pellerino, Alessia ^{[2
]}

Pronello, Edoardo ^{[3
]}

Palmiero, Rosa ^{[4
]}

Polo, Valentina ^{[5
]}

Vitaliani, Roberta ^{[5
]}

Trincia, Elena ^{[5
]}

Interno, Valeria ^{[6
]}

Porta, Camillo ^{[6
]}

Soffietti, Riccardo ^{[2
]}

Ruda, Roberta ^{[1
]}

机构：

[1] Castelfranco Veneto Treviso Hosp, Dept Neurol, Turin, Italy

[2] Univ & City Hlth & Sci Hosp, Div Neuro Oncol, Dept Neurosci, Turin, Italy

[3] Univ Piemonte Orientale, Dept Translat Med, Neurol Unit, Novara, Italy

[4] Univ & City Hlth & Sci, Div Neurooncol, Dept Neurosci, Turin, Italy

[5] Ca Foncello Hosp, Multidisciplinary Brain Tumor Board, Treviso, Italy

[6] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Div Med Oncol, Bari, Italy

来源：

NEURO-ONCOLOGY | 2022年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CTNI-25

引用

页码：76 / 76

页数：1

共 50 条

[1] REGORAFENIB IN RECURRENT GLIOBLASTOMA PATIENTS: A MULTICENTRIC REAL-LIFE STUDY
Bruno, F.
Pellerino, A.
Pronello, E.
Palmiero, R.
Polo, V
Vitaliani, R.
Trincia, E.
Interno, V
Porta, C.
Soffietti, R.
Ruda, R.
[J]. NEURO-ONCOLOGY, 2022, 24
[2] Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study
Lombardi, Giuseppe
Caccese, Mario
Padovan, Marta
Cerretti, Giulia
Pintacuda, Giovanna
Manara, Renzo
Di Sarra, Francesca
Zagonel, Vittorina
[J]. CANCERS, 2021, 13 (18)
[3] REGORAFENIB IN RECURRENT GLIOBLASTOMA PATIENTS: A LARGE REAL-LIFE EXPERIENCE
Caccese, Mario
Cerretti, Giulia
Padovan, Marta
Zagonel, Vittorina
Lombardi, Giuseppe
[J]. NEURO-ONCOLOGY, 2021, 23 : 71 - 71
[4] Regorafenib in recurrent glioblastoma patients: A large real-life experience
Caccese, M.
Cerretti, G.
Padovan, M.
Zagonel, V.
Lombardi, G.
[J]. ANNALS OF ONCOLOGY, 2021, 32 : S522 - S522
[5] REGORAFENIB IN RECURRENT GLIOBLASTOMA PATIENTS: A LARGE REAL-LIFE EXPERIENCE
Caccese, M.
Cerretti, G.
Padovan, M.
Zagonel, V.
Lombardi, G.
[J]. NEURO-ONCOLOGY, 2021, 23 : 41 - 41
[6] Regorafenib in recurrent glioblastoma patients: A large real-life experience.
Caccese, Mario
Cerretti, Giulia
Padovan, Marta
Zagonel, Vittorina
Lombardi, Giuseppe
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[7] Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?
Smolenschi, Cristina
Rassy, Elie
Pallud, Johan
Dezamis, Edouard
Copaciu, Razvan
Parker, Fabrice
Garcia, Gabriel
Lezghed, Naima
Colomba, Emeline
Khettab, Mohamed
Ammari, Sami
Fekhi, Mohamed
Martanovschi, Larisa
Benadhou, Lina
Knafo, Steven
Guyon, David
Cheaib, Bianca
Dhermain, Frederic
Dumont, Sarah Naomie
[J]. JOURNAL OF NEUROLOGY, 2023, 270 (05) : 2702 - 2714
[8] Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?
Cristina Smolenschi
Elie Rassy
Johan Pallud
Edouard Dezamis
Razvan Copaciu
Fabrice Parker
Gabriel Garcia
Naima Lezghed
Emeline Colomba
Mohamed Khettab
Sami Ammari
Mohamed Fekhi
Larisa Martanovschi
Lina Benadhou
Steven Knafo
David Guyon
Bianca Cheaib
Frederic Dhermain
Sarah Naomie Dumont
[J]. Journal of Neurology, 2023, 270 : 2702 - 2714
[9] Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
Roberta Rudà
Francesco Bruno
Alessia Pellerino
Edoardo Pronello
Rosa Palmiero
Luca Bertero
Stefania Crasto
Valentina Polo
Roberta Vitaliani
Elena Trincia
Valeria Internò
Camillo Porta
Riccardo Soffietti
[J]. Journal of Neuro-Oncology, 2022, 160 : 389 - 402
[10] Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
Ruda, Roberta
Bruno, Francesco
Pellerino, Alessia
Pronello, Edoardo
Palmiero, Rosa
Bertero, Luca
Crasto, Stefania
Polo, Valentina
Vitaliani, Roberta
Trincia, Elena
Interno, Valeria
Porta, Camillo
Soffietti, Riccardo
[J]. JOURNAL OF NEURO-ONCOLOGY, 2022, 160 (02) : 389 - 402

← 1 2 3 4 5 →